From AI-powered liquid biopsies to clinical decision support, we break down the vendors aiming to transform cancer care, diagnosis, and treatment.
Cancer is the second leading cause of death worldwide.
To fight this disease, tech companies are supporting patients, providers, and pharma players by developing tools to improve cancer care, diagnosis, and drug discovery.
Solutions like liquid biopsy screening are less invasive, faster, and more cost-effective than traditional biopsies, while cell behavior simulations can model tumor behavior to speed up drug R&D.
In the market map below, we identify 71 oncology tech vendors across 12 categories addressing critical aspects across the cancer patient journey.
Note: Our map includes public companies or private startups that have at least $2M in funding, have a Mosaic score of at least 300, and have received funding in the last 5 years. This market map is not exhaustive of the space.
Please click to enlarge.
Want to see more research? Join a demo of the CB Insights platform.
If you’re already a customer, log in here.
